Nautilus Biotechnology (NAUT) Research & Development (2020 - 2026)
Nautilus Biotechnology has reported Research & Development over the past 7 years, most recently at $9.7 million for Q1 2026.
- Quarterly results put Research & Development at $9.7 million for Q1 2026, down 15.85% from a year ago — trailing twelve months through Mar 2026 was $39.3 million (down 19.97% YoY), and the annual figure for FY2025 was $41.1 million, down 18.56%.
- Research & Development reached $9.7 million in Q1 2026 per NAUT's latest filing, up from $9.6 million in the prior quarter.
- Across five years, Research & Development topped out at $12.9 million in Q1 2024 and bottomed at $8.9 million in Q2 2022.
- Median Research & Development over the past 5 years was $10.9 million (2023), compared with a mean of $11.0 million.
- The largest annual shift saw Research & Development surged 99.75% in 2022 before it dropped 25.33% in 2025.
- Over 5 years, Research & Development stood at $9.6 million in 2022, then surged by 30.03% to $12.5 million in 2023, then increased by 2.86% to $12.8 million in 2024, then decreased by 25.33% to $9.6 million in 2025, then grew by 1.38% to $9.7 million in 2026.
- Business Quant data shows Research & Development for NAUT at $9.7 million in Q1 2026, $9.6 million in Q4 2025, and $9.6 million in Q3 2025.